RegKey Information

RegKey: Accelerating Drug Development with AI + Experts Bringing a drug to market can take more than a decade and cost billions. Along the way, biopharma teams manage thousands of documents, complex data, health authority interactions, and high-stakes decisions. Yet much of this work remains manual, fragmented, and dependent on scattered institutional knowledge. RegKey was built to change that. RegKey combines patented, purpose-built AI with human expert oversight to accelerate work across drug development, from clinical strategy and protocol optimization to regulatory preparation and submission. Because every drug, trial, and submission is unique, AI alone is not enough. RegKey pairs advanced AI with 50+ senior experts across regulatory affairs, clinical pharmacology, pharmacometrics, biostatistics, medical writing, CMC, and drug development strategy. Together, our experts have supported 1,000+ drug and device approvals. Our secure, unified platform helps organizations: • Build stronger clinical and regulatory strategies • Optimize protocols using data-driven insights • Interpret global regulatory guidance • Analyze competitive landscapes and emerging trends • Draft and review critical development and regulatory documents • Prepare for FDA and health authority meetings • Improve submission readiness and execution • Retrieve, analyze, and manage complex scientific knowledge For biopharma, the impact is clear: faster decisions, stronger submissions, reduced rework, and accelerated development timelines. Work that traditionally took months can now be completed in days. RegKey is more than an AI platform. It is a patented AI + expert intelligence platform built to help biopharma teams execute with confidence and bring therapies to patients faster. Because patients cannot wait. #RegKey #DrugDevelopment #Biopharma #ClinicalTrials #ProtocolDesign #RegulatoryAffairs #AI #HealthcareAI #LifeSciences #Biotech